The interleukins IL-17 and IL-5 are known to contribute to pathologic changes in skin structure and barrier functions as well as immune dysregulation in AD (Dong et al., 2016; Purushothaman et al., 2018). This evidence concerns the gene IL5 and Alzheimer disease.